Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MVA-SARS-2-S Vaccine Safety and Immunogenicity in Adults
NCT05950776Phase 2Withdrawn
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2021
- Primary completion
- Nov 2022
01
Overview
A Phase 2 trial of MVA-SARS-2-S in coronavirus disease 2019 (COVID-19), sponsored by University Medical Center Hamburg-Eppendorf. Planned start Jan 2021; status: withdrawn.
02
Drugs
MVA-SARS-2-S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05950776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05950776.